Sorrento Therapeutics Inc (NASDAQ:SRNE)

Delayed Data
As of Nov 26
 -0.02 / -0.34%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 22.50, with a high estimate of 26.00 and a low estimate of 19.00. The median estimate represents a +278.15% increase from the last price of 5.95.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 21.92%
Growthannually 26.92%


Growthquarterly -7.04%
Growthannually 7.44%
Key to the earnings and sales forecast charts.